GlassScriptPhysician profile
Marty Michael Meyer
NPI 1396787362
$1,681.23
in general payments reported to CMS, 2019-2025
8 companies · $260 in 2025
The $260 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $13.33 · 2021: $120 · 2022: $272 · 2023: $447 · 2024: $176 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $882.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $954.02 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $242.41 | 2021-2023 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $159.71 | 2019-2025 | Entyvio |
| Janssen Scientific Affairs, LLC | $120.46 | 2019 | |
| Pfizer INC. | $111.24 | 2019 | |
| Phathom Pharmaceuticals, INC. | $57.70 | 2024-2025 | Voquezna |
| Celltrion USA INC. | $18.20 | 2024 | Zymfentra |
| Ferring Pharmaceuticals INC. | $17.49 | 2023 | Rebyota |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marty Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.